Asbestos information clearinghouse. Hearing before the Subcommittee on Commerce, Transportation, and Tourism, Committee on Energy and Commerce, House of Representatives, Ninety-Ninth Congress, Second Session on H. R. 5078, July 17, 1986

Book · Wed Jan 01 00:00:00 EST 1986

OSTI ID:6992277

Representatives of US Gypsum Co., Pfizer Inc., and the Environmental Protection Agency (EPA) testified on the Asbestos Information Clearinghouse Act of 1986 (H.R. 5078), which calls for an information center with samples of materials containing asbestos to simplify the task of identifying their characteristics. The goal of the bill is to make judiciary processes more efficient. EPA opposes the bill on the grounds that the rulemaking and collection of samples from building owners and asbestos manufacturers and processors for analysis would shift the inefficiency from the judiciary arena to EPA. EPA argued that the identification of defendants is a private-sector issue, and that the activities that would be assigned to EPA would be outside its mission. Pfizer supported the legislation, while the spokesman for US Gypsum pointed out that if the purpose is to remove those defendants from litigation who are not involved, extensive sampling would be a waste of time. Additional material submitted for the record follows the text of H.R. 5078 and the testimony of four witnesses.

• OSTI ID: 6992277
• Resource Relation: Related Information: Serial No. 99-117
• Country of Publication: United States
• Language: English

Related Subjects

29 ENERGY PLANNING
POLICY AND ECONOMY
ASBESTOS
INFORMATION CENTERS
BUILDING MATERIALS
SAMPLING
BUILDINGS
HEALTH HAZARDS
HEARINGS
LAWSUITS
LEGISLATION
PUBLIC HEALTH
DOCUMENT TYPES
HAZARDS
MATERIALS
290300* - Energy Planning & Policy- Environment
Health
& Safety
293000 - Energy Planning & Policy- Policy
Legislation
& Regulation